We also tested whether treatment with rolipram (RP), a phosphodiesterase IV (PDE4) inhibitor, attenuated TG-induced cell death, since intracellular cAMP levels are decreased in HD models and RP treatment has beneficial effects [26], [27]. Here, PDE4A is linked to Huntington disease.